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I. Introduction
Epilepsy is the most common neurological disorder after a migraine, stroke, Alzheimer's disease 1 affecting 50 million individual worldwide. The average incidence of epilepsy each year in the U.S is estimated as 150,000 or 48 for every 100,000 people 2, 3 .The word epilepsy is derived from the Greek word epilambanien meaning to attack or seize. Epilepsy is not a disease, but a syndrome of different cerebral disorders of the central nervous system. This syndrome is charecterised by paroxysomal, excessive, and hypersynchronous discharges of large number of neurons these discharges disrupt normal brain function by creating fluctuations in electrochemical balances 4, 5 epilepsy treatment is still one of the major problems in medicine because of the uncontrolled seizures in some types of epilepsia, toxicity of medication, several side effects of currently used drugs, which may limit their maximal usefulness, obligation of administration of some anti-epileptics used symptomatically in the treatment of epilepsies for a long time even throughout one's life as they have to be used chronically, and also the risk of tolerance developing against the present drugs 6, 7 . Although there are a number of antiepileptic drugs available in the market, because of above mentioned reasons, development of new compounds having anticonvulsant activity is still necessary [8] [9] [10] [11] Isatin (1H-indole-2,3-dione,) was first obtained by Erdman and Laurent in 1841 as a product from the oxidation of indigo by nitric and chromic acids 13, 14 . Isatin (1H-indole-2, 3-dione) pharmacophore has attracted and has been attracting much attention from medicinal chemists because of great importance in their biological as well as synthetic approach of medicinal chemistry. The various derivatives of isatin are known to possess range of biological properties including antimicrobial 15, 16 , anticancer 17 , antiviral 18 , anticonvulsant 19, 20 , antidepressant 21 , anti-inflammatory and analgesic 22 . Surendranath pandeya 23, 24 et al, reported the synthesis and anti-convulsant activity of some novel n-methyl/acetyl, 5-unsubstituted isatin-3-semicarbazones 25 olesen and kanstrup reported synthesis and anti-convulsant activity of pyrido [2, 3-b] indoles 26 Evano et al synthesized and reported anti-convulsant activity of 1H-pyrido [3, 4-b] indole-4-carboxamide derivatives 27 . In the last few years, new isatin derivatives have been discovered which show potential hypnotic 28 , anti-bacterial 29 and MAO inhibitory 30 activity. Binedaline, amedalin, pindolol, siramesine and oxypertine etc are the marketed drugs bearing indole moiety used against different types of CNS disorders and which encouraged authors to further explore the pharmacological properties of the indole nucleus 30 Literature survey reveals that benzohydrazide exhibit wide variety of biological activities such as anti-microbial activity 31 , Hypnotic 32 and anti-convulsant 33 .
DOI: 10.9790/3008-1202028493 www.iosrjournals.org 85 | Page Keeping in view of biological importance of the two molecules, namely isatins with benzohydrazide has been felt worthwhile as depicted in scheme. It is evident from the literature survey that isatin derivatives, and benzo hydrazide derivatives showing more promising effects central nervous system.Keeping in view of these two molecular moieties into a single molecular frame as a model for molecular conjunction by appropriate synthetic routes and to screen them for anti-convulsant activity and neurotoxicity. The objective of the present study was to design a synthetic scheme to carry out molecular conjunction between isatin and benzohydrazide derivatives and to screen the resultant novel derivatives for anticonvulsant activity using in vitro docking and in vivo studies.
II. Materials And Methods
The compounds were mostly synthesized by conventional synthetic methods and as described in experimental section and also by the methods established in our laboratory. Isatin was synthesised by using sandmayer method and it consists reaction of aniline(I) with chloral hydrate and hydroxylamine hydrochloride in aqueous sodium sulphate to form an isonitrosoacetanilide, which after isolation, when treated with concentrated sulphuric acid, furnishes isatin in > 75% overall yield 34 Isonitrosoacetanilides (I1): In a 5lit. RB flask, chloral hydrate (0.54M) and 1200mL of water were placed. To this solution ,crystallized sodium sulphate (1300g) was then added followed by a solution of an appropriate aromatic aniline(I) in 300Ml of water and concentrated hydrochloric acid (0.52M). Finally, a solution of hydroxylamine HCl (1.58mol) in 500mL of water was added. The contents of the flask were heated over a wiregauge by a Mecker burner so that vigorous boiling begins in about 45 minutes. After 1 to 2 minutes of vigorous boiling the reaction was completed. During the heating period itself the crystals of isonitrosoacetanilides started separating out. on cooling under the current of water, the entire product was solidified. It was filtered under suction, air dried, and purified by recrystallization from Methanol(s). Indole-2,3-diones (III): Sulphuric acid (600g, d, 1.84, 326mL) were warmed at 50°C in a one liter RB flask fitted with an efficient mechanical stirrer and to this, finely powdered appropriate isonitrosoacetanilide (II, 0.46M) was added at such a rate so as to maintain the temperature between60°C to70°C but not higher. External cooling was applied at this stage so that the reaction could be carried out more rapidly .After the addition of iso nitroso compound the temperature of the solution was raised to 80°C and maintained the same for 10 minutes, to complete the reaction. Then the reaction mixture was cooled to room temperature and poured on to crushed ice (2.5kg) while stirring. After standing for about half-an-hour, the product separated was filtered, washed several times with small portions of cold water, and dried. Purification of the compound was affected by the recrystallization from methanol.
2.2.2.Preparation of 4-hyydroxy benzohydrazides (V):
In 500ml RBF The mixture of methyl paraben (IV) (0.02 mol) and hydrazine hydrate (99%), (30 mL, 0.6 mol) was refluxed for 12 h. The excess solvent was removed under vacuum up to 10 mL. The reaction mixture was cooled at 4-5°C. The separated solid crystals (2) were filtered and washed with cold water. The crystals were dried and purified by recrystallization from ethanol (99.9%). Yield: 90% .M.P. 246-248˚C.
2.2.3.Preparation of N,N-Dialkyl aminoalkoxy benzohydrazides (VI):
A mixture of (0.1moles) 4-hydroxy benzohydrazide (V) (0.12mol) alkyl halide in 60ml alcoholic KOH refluxed for 24hr at room temperature . the reaction mixture was filtered and filtrate taken into benzene , washed with water and with Hydrochloric acid. combine aqueous acid extracts and were basify with ammonium hydroxide and extracted with chloroform the organic extracts are dried over calcium sulphate and the product recrystallized from ethyl acetate. %yield:80, melting point:230-232˚c
2.2.4.Preparation of N,N-dialkylaminoalkoxy-2-oxo-indole-3-ylidenebenzohydrazides (VII):
A mixture of an appropriate indole-2,3-dione(III,0.01mol.)
Dialkyl aminoalkoxy benzohydrazides (IV,0.01mol.) In dry methanol (50ml) was heated under reflux for 30 min . mixture was filtered and dried and purified by methanol. The physical data of the compounds were presented in 
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III. Anticonvulsant Activity
It is evident from the literature that isatins exhibits anti-convulsant, psychotropic and angiogenic, properties therefore, it has been worthwhile to screen the new isatin-benzohydrazide derivatives for CNS activity.All the synthesised isatins were subjected to the fallowing screening tests
Acute toxicity:
Healthy and adult male albino mice weighing between 20-25g were used in the investigation. Animals were fasted for 24 hr and divided into groups of six animals each. The test compounds, dissolved in DMSO were administered, orally, at the dose of 5mg to 300mg per kg(b.w.) The controlled group of animals received only the vehicle(DMSO) the animals were observed for 48hr from the time of administration of the test compound to record the mortality.
Locomotor activity:
The locomotor activity was studied by using actophotometer, which operates on photoelectric cells, which are connected in circuit with a counter. When a beam of light falling on the photocells is cut of by animals, a count was recorded. Healthy mice weighing between20-25gm were used. Animals were fasted for overnight and divided into groups of six animals each. The test compounds were dissolved in DMSO and administered at a dose of 50mg/kg body weight orally and the control group animals received only vehicle (DMSO) the response (counts) was recorded after 60 min. administration of test compound. The animals were placed in actophotometer for 10min .and scores were recorded(deflections)the results were compared with the control and presented in table-2: All the test compounds were administered in a dose of 50 mg/kg (b.wt) i.p. and motor activity in an open field was determined data are expressed as the number of movements per minute(mean) percentage decrease in activity was calculated 
. Maximal electroshock induced convulsions:
The anti-convulsant activity was studied by using electroconvulsometer. Healthy male mice weighing between 20-25gm, were fasted for overnight and divided into six groups of six animals each . The test compounds suspended in o.1% sodium CMC were administered at a dose of 50 mg/kg body weight orally. The control group animals received only vehicle (DMSO). The test started 30 min after oral administration. n=six in each group. All animals are recovered The compounds were tested at a dose of 50mg/kg(oral) 
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Pentylenetetrazole induced convulsions:
Animals were divided into three groups each comprising of 6 animals in each group one group was used for studying the effects of pentylenetetrazole alone (control) and other groups for studying the protective effect of phenobarbitone(standard) as well as studying the anti-convulsant effect of test compounds. Injected pentylenetetrazole to control and noted the onset of action (indicated by straubs tail, jerky movements of whole body and convulsions ) and severity of convulsions due to the drug. injected phenobarbitone to second group of animals and test compounds to third group of animals after 30 min. Injected pentylenetetrazole to these animals which received phenobarbitone and test compounds. Noted either delay or complete abolition of convulsions in mice treated with phenobarbitone and test compounds 39 . And results were presented in table-4 
IV. Results And Discussions
Novel isatin derivatives were synthesised by condensation of isatins with alkylated benzohydrazides in the presence of methanol. Details were given in scheme and Structures of all synthesised compounds were given in figure-1, Physical data were shown in table-1.
In-vivo anti-convulsant activity:
All synthesised compounds were evaluated for in-vivo anti-convulsant activity at the dose of 50 mg/kg by chemically induced convulsions and electrically induced by PTZ method and MES method. From the data it was revealed that all the tested compounds significantly reduced chemically induced convulsions and electrically induced convulsions. And the results were presented in table-3 and 4.Among the tested compounds, VIIb (R-CH 3 ) protected more than 80% of the mice against MES and PTZ induced convulsions. Compounds VIId,VIIc,VIIa,VIIe were found to be next in the order of reducing the duration of convulsions in both MES and PTZ methods.Interestingly, compounds with electron releasing substituents (R-CH 3 ) at C-5 of isatin nucleus produced 80% protection against MES and PTZ induced convulsions. Compounds VIIc(R-Cl), VIId(RBr), VIId(R-F), VIIe(R-H) exhibited substantial activity with 78.7%, 72.8%, 68.9%, 70.8%. Compounds with electron releasing substituents (R-CH 3 ) at C-5 of isatin nucleus produced more anticonvulsant activity. Whereas compounds with electron withdrawing substituents such as (R-Cl, Br, F) at C-5 of isatin nucleus are next in the order of activity.
Docking-studies:
Docking was performed on windows 2007 using MOE 2008.10 version. 5HT2C mouse receptor was retrieved from the protein data bank (PDB code: 2MHO) and the enzyme was visualized using sequence option and further co-factors were deleted. The partial charge of the protein was adjusted with the help of force field method AMBER 99. Later, the protein was subjected to 3D protonation at cut off 12.0, and further hydrogen was added according to standard geometry and the receptor was energy minimized using force field MMFF94x at 0.01 KJ mole gradients. After obtaining docking results, best pose was retained to understand molecular interaction out of 30 poses given for each chemical structure. 
V. Conclusion
Present study described the synthesis and characterization of a novel NN-dialkylaminoalkoxy-2-oxoindole-3-ylidene benzohydrazide derivatives. Among the tested compounds, VIIb (R-CH 3 ) has protected more than 80% of the mice against MES and PTZ induced convulsions. Compounds VIId, VIIc, VIIa and VIIe were found to be next in the order of reducing the duration of convulsions in both MES and PTZ methods. Compounds having electron donating groups at C-5 of isatin nucleus seemed to be necessary in providing higher anticonvulsant activity. Other substituents at various positions are next in the order of activity. It is evident from the anticonvulsant activity that electron donating groups seemed to be necessary moieties in showing higher anticonvulsant activity and in vitro docking studies have confirmed the same.
